GENFIT: Announces Results from Interim Analysis of RESOLVE-IT Phase 3 Trial of Elafibranor in Adults with NASH and Fibrosis
Glucagon-like peptide-1 (GLP-1) receptor agonists, also known as incretin mimetics, are widely used in the treatment of type 2 diabetes and obesity [4,5]
Daek P, Drabik D, Woczaska H, Fory A, Jagas M, Jdruchniewicz N, Przybyo M, Witkiewicz W, Langner M (2022) Bioavailability by design Vitamin D 3 liposomal delivery vehicles, Nanomedicine
All animal experiments agreed with the new Italian regulations (D.Lgs 2014/26), EU regulations (EU Directive 2010/63), and the ARRIVE guidelines
Monitoring and Management Strategies Experts advocate for close monitoring of patients on semaglutide, especially those with a history of acid reflux or other gastrointestinal disorders
Tirzepatide (brand names Mounjaro and Zepbound) is the main alternative in the GLP-1 medication class